Whole brain radiotherapy: prognostic factors and results of a radiation boost delivered through a conventional linear accelerator.

[1]  M. Taphoorn,et al.  Dose-effect relation in stereotactic radiotherapy for brain metastases. A systematic review. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[2]  Cyrus Chargari,et al.  Whole-brain radiation therapy in breast cancer patients with brain metastases , 2010, Nature Reviews Clinical Oncology.

[3]  Cyrus Chargari,et al.  Could helical tomotherapy do whole brain radiotherapy and radiosurgery? , 2010, World Journal of Radiology.

[4]  P. Brown,et al.  Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4,259 patients. , 2009, International journal of radiation oncology, biology, physics.

[5]  Angelina Bockelbrink,et al.  Stereotactic radiosurgery for the treatment of brain metastases. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[6]  Walter Curran,et al.  A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1,960 patients in the RTOG database. , 2008, International journal of radiation oncology, biology, physics.

[7]  D. Rades,et al.  A boost in addition to whole‐brain radiotherapy improves patient outcome after resection of 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients , 2007, Cancer.

[8]  D. Rades,et al.  Dose escalation beyond 30 grays in 10 fractions for patients with multiple brain metastases , 2007, Cancer.

[9]  E. Rakovitch,et al.  Radiotherapeutic management of brain metastases: a systematic review and meta-analysis. , 2005, Cancer treatment reviews.

[10]  J. Posner,et al.  Brain metastases: epidemiology and pathophysiology , 2005, Journal of Neuro-Oncology.

[11]  G. Hruby,et al.  Survival following whole brain radiation treatment for cerebral metastases: an audit of 474 patients. , 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[12]  Maria Werner-Wasik,et al.  Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial , 2004, The Lancet.

[13]  J. Posner.  Brain metastases: 1995. A brief review , 1996, Journal of Neuro-Oncology.

[14]  Roy A Patchell,et al.  The management of brain metastases. , 2003, Cancer treatment reviews.

[15]  P. Levendag,et al.  Identification of prognostic factors in patients with brain metastases: a review of 1292 patients. , 1999, International journal of radiation oncology, biology, physics.

[16]  L Gaspar,et al.  Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. , 1997, International journal of radiation oncology, biology, physics.

[17]  B. Young,et al.  Demographics of brain metastasis. , 1996, Neurosurgery clinics of North America.

[18]  H. Ford,et al.  The influence of extent and local management on the outcome of radiotherapy for brain metastases. , 1990, International journal of radiation oncology, biology, physics.

[19]  R. Gelber,et al.  Ultra-rapid high dose irradiation schedules for the palliation of brain metastases: final results of the first two studies by the Radiation Therapy Oncology Group. , 1981, International journal of radiation oncology, biology, physics.